Jeffrey H. Buchalter
Member of the Board of Directors
Molecular Partners
Switzerland
Biography
Jeffrey H. Buchalter is the Chairman and Chief Executive Officer of KBS Healthcare Consulting, Florida, and he serves as Chairman of the board of directors of UK-based Inivata Ltd. Mr. Buchalter served in various senior executive positions, including being CEO of NASDAQ-listed Enzon (NASDAQ:ENZN) and of Ilex Oncology, as well as a Senior Executive at Pharmacia, Wyeth and Schering-Plough. Mr. Buchalter serves as member of the board of directors of Symphogen A/S, Denmark. He brings many years of strategic and operational experience in the life science industry with a focus in the commercial positioning and development of therapeutics in oncology. Mr. Buchalter graduated from Seton Hall University, Newark, NJ, and he holds Bachelor’s degrees in both, Science and Finance. Moreover, he earned an MBA at Temple University, Philadelphia, PA. Mr. Buchalter received the American Cancer Society’s Joseph F. Buckley Memorial Award for commitment to cancer control and involvement in the oncology pharmaceutical field. He also served as Collaborating Partner in President’s National Dialogue on Cancer (invited by President George Bush).
Research Interest
oncology pharmaceutical field
